Join BOPA
Back to news articles

PUBLIC CONSULTATION NOW OPEN ** Draft International Consensus Guideline on Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) **

By BOPA Committee on 11th May 2022

The ADDIKD draft guideline is open for public consultation until midnight (AEST) 31st May 2022.  The BOPA Committee would appreciate your input with this process.

The Draft Guideline can be accessed here: https://www.eviq.org.au/getmedia/7f42c39e-2100-40aa-b358-575c485ce3da/Draft-ADDIKD-Guideline-V7.aspx

If you have any questions, please contact Geeta Sandhu on [email protected] submit you feedback please scan the QR code below or see the consultation information here: https://www.bopa.org.uk/resources/addikd-flyer-final/

Latest News

By Joseph Williams on 30th April 2024

Pharmacists’ Essential Guide to Haematology – UCLH Cancer Academy

UCLH Cancer Academy would like to invite you to an educational program designed to help pharmacists’ understanding of malignant haematology. SACT-accredited pharmacists who are new to haematology or wish to…

Read article
By BOPA Committee on 30th April 2024

BOPA Passport and UTIC

Over the next few days we will rolling out an update to the current Passport content based on user feedback and errors highlighted. This includes updates to MCQs and a…

Read article
By BOPA Committee on 30th April 2024

Understanding targeted therapies and immunotherapies for cancer (UTIC)- learning course now available

ISOPP (The International Society of Oncology Pharmacy Practitioners) and BOPA (The British Oncology Pharmacy Association) are pleased to announce this joint collaboration project – UTIC (Understanding targeted therapies and immunotherapies…

Read article
By BOPA Committee on 30th April 2024

Clinical Pharmacy Congress Awards 2024

BOPA and Netty Cracknell have been shortlisted for the CPC 2024 awards!  For more information please the following website: CPC AWARDS 2024 SHORTLIST – Clinical Pharmacy Congress  

Read article